Newgenivf Group Limited disclosed that it traded SOL, BTC, ETH and XRP during 2025 as part of a digital-asset treasury program outside its core in-vitro fertilization business. The company bought and sold 146,432.14 XRP, ending the year with no XRP and a $10,849 realized gain. Bitcoin generated $12,569 in realized gains and Ether $223. Newgenivf retained 13,000.23 SOL at Dec. 31, 2025, valued at $1.63 million against a $2.91 million cost basis, resulting in a $1,275,395 unrealized valuation loss. Total realized crypto gains of $942,915 were offset by the Solana markdown, leaving a $332,480 net crypto loss in other income and expense. The filing does not establish whether Newgenivf still holds the SOL, and it provides no post-year-end trading update.